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Benign paroxysmal positional vertigo (BPPV) presentations are unique opportunities to simultaneously improve the
effectiveness and efficiency of care. The test and treatment for BPPV—the Dix–Hallpike test (DHT) and the canalith
repositioning maneuver (CRM), respectively—are supported by two evidence-based guidelines (American Academy
of Otolaryngology—Head and Neck Surgery and American Academy of Neurology). With these processes, patients
can be readily identified and treated at the bedside, quickly and without expensive tests. Patients randomized to the
CRM have a cure rate of 80% at 24 h, compared to only 10% of controls. Despite this large effect size, less than 10%
of affected patients receive the treatment, which shows that the management of BPPV in routine care is suboptimal.
Future research is necessary to disseminate and implement the DHT and the CRM into routine practice.
Keywords: dizziness; vertigo; benign paroxysmal positional vertigo; Dix–Hallpike test; canalith repositioning
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Introduction
Benign paroxysmal positional vertigo (BPPV) is
caused by free-floating particles that enter an inner
ear semicircular canal.1 The particles originate in
the otolith organs, which are located in the cen-
tral chamber of the inner ear. Each otolith organ
contains otoconia, which can break free from the
organ and result in BPPV symptoms if they enter
a semicircular canal (the otoconia are often called
canalithswhen they enter a canal), typically the pos-
terior canal. When the particles move within the
canal, the sensory organ of the canal, the cupula,
is stimulated, resulting in a burst of nystagmus via
the vestibular–ocular pathways. Nystagmus is an eye
movement with a fast phase and a slow phase, such
that the eyes appear to be beating in the direction of
the fast phase.
BPPV is common and is associated with dis-
ability. An epidemiological study of dizziness from
Germany used random-digit dial telephone–survey
methodology and a validated method to classify
causes of dizziness. From this study, BPPV was
found to be themost common peripheral vestibular
disorder, with an estimated lifetime prevalence of
2.4%.2 The German study also found that BPPV
accounts for 8% of individuals who report with
moderate or severe dizziness.2 “Benign” is a mis-
nomer in the label of BPPV. BPPV patients experi-
ence substantial inconveniences anddisabilities dur-
ing symptomatic periods.2,3 In the German study,
nearly one in four BPPV patients stopped driving a
car, one in three missed work, and more than three
in four sought medical consultation.2
The Dix–Hallpike test (DHT; Fig. 1) is the gold
standard test for BPPV.4,5 It is a simple bedside test.
A positive test is indicated by up-beating and tor-
sional nystagmus triggered by the DHT that lasts
about 10–20 s. Even when physicians use the DHT,
there is the possibility that they may not inter-
pret the results correctly.6–8 Common errors include
calling the test positive for symptoms (rather than
nystagmus) and making a BPPV diagnosis when
there is any pattern of nystagmus observed.9 Clini-
cians must be aware that different patterns of nys-
tagmus observed on the DHT can be attributable
to other disorders. For example, patients with
vestibular neuritis have horizontal and persistent
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Figure 1. Dix–Hallpike maneuver for diagnosis of right posterior BPPV. The patient’s head is turned 45° toward the side to be
tested and then laid back quickly. If BPPV is present, nystagmus ensues, usually within seconds. Reproduced from Ref. 4.
(not transient) nystagmus that may become most
apparent during positional testing. Central disor-
ders can also cause positional, typically down-beat
nystagmus.
The canalith repositioning maneuver (CRM) is
the treatment for BPPV (Fig. 2). The CRM is used
to move the canaliths from the inferior portion of
the involved posterior canal back into the central
chamber of the inner ear.4 In this location, the posi-
tional vertigo no longer occurs. The first two steps
of the CRM are the same as the DHT. If the DHT is
positive on the right side, then there are three more
steps that are used to move the particles out of the
canal.
Evidence-based guidelines supporting the DHT
and the CRM were published in 2008 by the Amer-
ican Academy of Otolaryngology—Head and Neck
Surgery and theAmericanAcademyofNeurology.4,5
Additional systematic reviews also support theDHT
and theCRM.10–14 The primary clinical randomized
controlled trials (RCTs) demonstrate the resolution
of BPPV symptoms (outcomesmeasured at 1 day to
4 weeks) in patients treated with the CRM.15–19 In
these studies, 61–80% of treated patients had reso-
lution after just one treatment, compared with 10–
48% of untreated patients. These effect sizes trans-
late into a number needed to treat ranging from 1.4
to 3.7, which is among the most substantial effects
achievable in clinical medicine. In the study assess-
ing outcome at 24 h, 80% of treated patients were
cured, versus only 10% of controls.15 Substantial
benefit has also been demonstrated in RCTs from
primary care settings.20,21 Since the publication of
the guideline statements in 2008, additional high-
quality trials have been performed to support the
use of other CRMs specific for the horizontal canal
variants of BPPV.22,23
Suboptimal management of BPPV
processes in routine practice
Despite the substantial evidence supporting the
benefit of identifying BPPV and treating it with
the CRM, the DHT and the CRM are substan-
tially underutilized.2,24,25 The German epidemio-
logical study found that less than 10% of BPPV
patients are treated with the CRM.2 Research from
a population-based study of emergency department
(ED) presentations in the United States found that
78% of patients diagnosed by the treating physician
with BPPV did not have the DHT documented and
96.1% did not have a CRMdocumented (Table 1).25
The reasons for the underuse of the DHT and CRM
have not been systematically studied and are likely to
be complex and involve several constructs, includ-
ing knowledge gaps, clinical inertia, and a low per-
ception of one’s ability to perform the DHT and
the CRM. Other factors may also play roles, such
as a lack of marketing forces, payment incentives,
and availability of BPPV experts to consult in rou-
tine care settings to support and teach frontline
providers at the point of care.
The ED population-based study also found that
the DHT was less likely to be documented in dizzi-
ness presentations over time (time period of 2008–
2011). For every increase in month, the odds of
utilization of the DHT decreased by 3% (odds ratio,
0.97; 95% confidence interval, 0.95–0.99). This is
an important finding because the decline in use
over time suggests that a targeted implementation
intervention will likely be required to increase the
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Figure 2. Canalith repositioning procedure for right-sided BPPV. Steps 1 and 2 are identical to the Dix–Hallpike maneuver. The
patient is held in the right head–hanging position (step 2) for 20–30 s, and then in step 3 the head is turned 90° toward the unaffected
side. Step 3 is held for 20–30 s before turning the head another 90° (step 4) so the head is nearly in the face-down position. Step
4 is held for 20–30 s, and then the patient is brought to the sitting-up position. The movement of the otolith material within the
labyrinth is depicted with each step, showing how otoliths are moved from the semicircular canal to the vestibule. Although it is
advisable for the examiner to guide the patient through these steps, it is the patient’s head position that is the key to a successful
treatment. Reproduced from Ref. 4.
use of the DHT. Another important finding from
this study was that a substantial proportion of the
variation in the documentation of the DHT could
be explained at the physician level. In the model,
there were a total of 73 unique providers who saw
a median of 25 patients (interquartile range, 5–72).
The intraclass correlation coefficient for the physi-
cian level was 0.50, meaning that half of the varia-
tion in the probability of DHT utilization was due
to physician practice difference and the other half
was attributable to patient-level factors and random
variation. Variation in practice patterns that occurs
at the physician level (i.e., controlling for patient-
level factors) is generally considered unwanted,26,27
and this finding further highlights the lack of broad
diffusion of BPPV knowledge to the frontline of
care.
The optimal use of the DHT and the CRMmight
also contribute to improved efficiencies via reduc-
tions in the use of unnecessary tests, length of stay
in the ED, or hospital admission. For example, the
use of computed tomography (CT) in BPPV cases
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Table 1. Information regarding testing andmanagement processes documented in visits to the ED for dizziness with
subsequent discharge25
Visits for episodic Visits with BPPV
All visits N (% presentations N diagnosis N
Total of total (3522)) (% of total (1484)) (% of total (156))
Dix–Hallpike test
Documented 137 (3.9%) 89 (6.0%) 34 (21.8%)
Resultsa
Positiveb 94 (2.7%) 67 (4.5%) 29 (18.6%)
Negative 37 (1.1%) 22 (1.5%) 3 (1.9%)
Unknown 6 (0.2%) 0 (0.0%) 2 (1.3%)
Canalith repositioning maneuver
Documented as donec ,d 8 (0.2%) 4 (0.3%) 6 (3.9%)
Additional mentione 9 (0.3%) 8 (0.5%) 9 (5.7%)
Consultations
Neurology 16 (0.5%) 8 (0.5%) 0 (0.0%)
Otolaryngology 2 (0.1%) 2 (0.1%) 0 (0.0%)
Head CT 1162 (33.0%) 488 (32.9%) 46 (29.5%)
aPositive or negative results were based on nystagmus in 15.3% (21/137), symptoms only in 11.7% (16/137), and
unknown (e.g., described as “positive” or “negative” or results not reported) in 73.0% (100/137). None of the visits
with positive test results described the characteristic nystagmus pattern of BPPV (i.e., upbeat torsional nystagmus).
bWhen the test was positive, the side affected was documented in 47.9% (45/94) of visits.
cThe side that the maneuver was performed on was only documented in one visit.
dThe patient’s response to the maneuver was reported in six visits and all responses were based on symptoms (three
with documented improvement and three with no improvement).
eIn these nine additional visits, themaneuver wasmentioned but not documented as performed. One of these indicated
that instructions for the maneuver were provided, whereas the others suggested follow-up care for the maneuver.
CT, computerized tomography.
in the ED illustrates how optimal DHT and CRM
utilization might affect efficiencies. The use of head
CT in EDdizziness visits is associatedwith increased
length of stay in the ED,28 in addition to adding costs
and radiation exposure. Head CT is also typically
unnecessary or even unwarranted in BPPV cases.5
Despite these factors, patients diagnosedwith BPPV
in the ED frequently receive head CT scans.25,29
Therefore, frontline providers might feel less com-
pelled to order CT scans in BPPV cases if the DHT
and the CRM were used more optimally. Reducing
unnecessaryCT scansmight result in reduced length
of stay and costs. However, it remains possible that
other factors, such as payment andmalpractice con-
cerns, may also need to change in order to reduce
the use of unnecessary tests in BPPV patients.
Future steps
It should be possible to improve the appropriate
use of the DHT and the CRM for patients with
BPPV. One potential mechanism to improve DHT
and CRM use is dissemination and implementa-
tion research targeting frontline physicians such as
primary care and emergency medicine doctors.
Frontline physicians want support for dizziness pre-
sentations. A survey of ED physicians about priori-
ties for the development of clinical decision support
(1150 respondents) ranked vertigo as the number
one topic in adult ED presentations.30 The “lowest
hanging fruit” in the opportunity to achieve mean-
ingful improvements in dizziness presentations is
BPPV, which is common, readily identifiable, and
treatable at the bedside. No laboratory or imaging
studies are needed, and, in fact, these are explicitly
discouraged in guideline statements.5 EDphysicians
have strongly advocated for the use of BPPV pro-
cesses (even stopping an ED-based trial for ethical
reasons given the effect size at interim analysis).20
Research initiated by emergency medicine physi-
cians indicates that these providers can effectively
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identify and treat BPPV patients.20 The target with
this type of research is the physician’s behavioral
intent, and interventions in this regard should be
rooted in behavior-change theoretical models. The
key determinants of behavioral intent are attitude
toward the behavior, subjective norms, and per-
ceived control of behavior, which account for almost
30% of the variance in behavior and almost 40%
of the variance in behavioral intent.31 There is no
unifying theory of physician behavior change tested
among physicians in practice.32,33 but multifaceted
approaches yield promising results.32,34–36 Champi-
ons, education, organizational change, and decision
support also show some evidence of benefit.35–37
Research that aims to implement changes in
physicianmanagementofBPPVshould alsouse spe-
cific frameworks such as the Consolidated Frame-
work for Implementation Research (CFIR) to guide
data collection and analyses.38 TheCFIR’s fivemajor
domains are the intervention characteristics (e.g.,
providers may not trust the evidence base used to
develop the BPPV guidelines), outer setting (e.g.,
reimbursement policies may incentivize physicians
toorderunnecessary tests), inner setting (e.g., physi-
cians may have other higher priorities), character-
istics of the individuals involved, and the process
by which implementation is accomplished (e.g., the
use of local champions).
It may also be possible to increase the appro-
priate treatment of BPPV patients with the use of
self-diagnosis and self-treatment interventions. Pre-
sentations of BPPV are very unique, which distin-
guishes it from other causes of dizziness, making it
an ideal target for self-diagnosis tools. The attacks
have specific positional triggers and are very short
in duration. A study based in Germany found that
a standardized telephone interview accurately clas-
sified BPPV cases measured against vestibular spe-
cialist clinical evaluation (specificity, 92%; sensitiv-
ity, 88%).2 Furthermore, three studies have shown
that patients can effectively self-treat BPPV.39–41
However, patients in these studies received the
BPPV diagnosis from a specialist and had in-person
verbal instruction during the performance of the
maneuver.39,40
Patients are already using information from
YouTube for self-diagnosis and self-treatment.42 A
systematic review of YouTube videos and associated
comments regarding the CRM found that videos
are readily available and widely viewed. The video
on YouTube that had the most views was pro-
duced by the American Academy of Neurology.
Themes derived from a qualitative analysis of
424 posted comments associated with the videos
included patients self-treating with the maneuver
after reviewing the videos and providers using the
videos as a prescribed treatment or for educational
purposes. Concern exists, however, regarding the
broad dissemination of these videos to patients
because none of the videos have undergone devel-
opment/testing, important diagnostic information
is typically missing, and errors in the maneuver
demonstration are present in 36% of identified
videos.42
Conclusions
The diagnosis and treatment of BPPV should be a
priority in clinical medicine because the disorder is
common, readily identifiedusing a simple andquick
test, and readily treatable using a bedside positional
maneuver that has been demonstrated to be highly
effective. The DHT and the CRM are supported
by primary research, systematic reviews, and two
guideline statements. Despite this, the DHT and the
CRM are substantially underutilized in routine care
settings. Further, other unnecessary and potentially
harmful tests and treatments are instead frequently
being used in BPPV patients. Future research is
needed to disseminate and implement the optimal
use of the DHT and CRM.
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